MRG007

DRUG2 trials

Sponsors

ArriVent BioPharma, Inc., Lepu Biopharma Co., Ltd.

Conditions

Advanced Colorectal CancerColorectal CancerGastric CancerLocally Advanced or Metastatic Solid TumorsPancreatic Cancer

Phase 1

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

RecruitingNCT07066657

ArriVent BioPharma, Inc.Colorectal Cancer, Gastric Cancer, Locally Advanced or Metastatic Solid Tumors +1

Start: 2025-07-25End: 2030-12-01Target: 572Updated: 2026-08-13

A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer

Not yet recruitingNCT07737600

Lepu Biopharma Co., Ltd.Advanced Colorectal Cancer

Start: 2026-08-01End: 2029-12-01Target: 316Updated: 2026-08-04